Wang YF, et al. - Experts sought to validate the newly identified 10 novel loci associated with systemic lupus erythematosus (SLE) and evaluate the role of SLE genetics in drug repositioning through genome-wide association studies (GWAS). As per data, 3 novel loci, ST3AGL4, MFHAS1 and CSNK2A2, associated with SLE were identified and demonstrated the role of SLE GWAS findings in drug repositioning. The SLE risk genes were seen more likely to be interacting proteins with targets of approved SLE drugs. The association of the CD226 locus with SLE was also confirmed.